NovaBridge Biosciences (NBP) Other Working Capital Changes (2020 - 2025)

NovaBridge Biosciences (NBP) posted quarterly Other Working Capital Changes of -$732000.0 for Q4 2025, down 130.98% year-on-year from $2.4 million in Q4 2024, and up 49.06% on a QoQ basis from -$1.4 million in Q3 2025.

NovaBridge Biosciences (NBP) Other Working Capital Changes (2020 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Other Working Capital Changes for 2 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Working Capital Changes changed N/A year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $914000.0 (up 417.49% YoY) and the FY2025 annual result came in at $512000.0, up 583.02% from the prior year.
  • Other Working Capital Changes climbed to -$732000.0 in Q4 2025 per NBP's latest filing, from -$1.4 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for NBP reached as high as $1.1 million in Q4 2025 and fell as low as -$206000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 NovaBridge Biosciences 389.86 Mn 389.86 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.12 Mn
Dec 31, 2025 1.12 Mn
Dec 31, 2025 1.12 Mn
Sep 30, 2025 -206,000.00
Sep 30, 2025 -206,000.00
Sep 30, 2025 -206,000.00
Dec 31, 2020 -144,706.67
Dec 31, 2020 -144,706.67
Dec 31, 2020 -144,706.67
Sep 30, 2020 -143,178.71
Sep 30, 2020 -143,178.71
Sep 30, 2020 -143,178.71